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Background: White matter changes (WMC) are a common finding among older adults
and patients with Parkinson’s disease (PD), and have been associated with, e.g., gait
deficits and executive dysfunction. How the factors age and PD influence WMC-related
deficits is, to our best knowledge, not investigated to date. We hypothesized that
advanced age and presence of PD leads to WMC-related symptoms while practicing
tasks with a low complexity level, and low age and absence of PD leads to WMC-related
symptoms while practicing tasks with a high complexity level.
Methods: Hundred and thirty-eight participants [65 young persons without PD (50–69
years, yPn), 22 young PD patients (50–69 years, yPD), 36 old persons without PD (70–
89 years, oPn) and 15 old PD patients (70–89 years, oPD)] were included. Presence and
severity of WMC were determined with the modified Fazekas score. Velocity of walking
under single and dual tasking conditions and the Trail Making Test (TMT) were used as
gait and executive function parameters. Correlations between presence and severity of
WMC, and gait and executive function parameters were tested in yPn, yPD, oPn, and
oPD using Spearman’s rank correlation, and significance between groups was evaluated
with Fisher’s z-transformed correlation coefficient.
Results: yPn and yPD, as well as oPn and oPD did not differ regarding demographic and
clinical parameters. Severity of WMC was not significantly different between groups. yPn
and yPD displayed significant correlations of WMC with executive function parameters
at low levels of task complexity, oPn at intermediate, and oPD at high complexity levels.
Conclusion: This study argues for a relevant association of age and PD-related brain
pathology with WMC-related gait and executive function deficits.
Keywords: cognition, dual tasking, older adults, Parkinson’s disease, white matter changes
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INTRODUCTION
White matter changes (WMC) are a common finding in brain
imaging such as MRI. They increase with age (Breteler et al.,
1994) and are thought to reflect microangiopathy (Schmidt et al.,
2004). Evidence emerges that WMC have a relevant influence
on daily activity- and life quality-relevant features such as gait
and executive functioning. This has been shown for older adults
in general (Marshall et al., 2006; Baezner et al., 2008; de Laat
et al., 2010; Smith et al., 2011; Zheng et al., 2012) and for
patients with Parkinson’s disease (PD) (Sohn and Kim, 1998;
Kandiah et al., 2013; Theilmann et al., 2013; Veselý et al., 2015;
Veselý and Rektor, 2016) in particular. The influence on both,
gait and executive functioning, is plausible as a dynamically
expandingmass of scientific literature shows that gait functioning
depends on the input from supraspinal centers, especially those
associated with executive functioning (meaning mental faculties
of controlled, planned and anticipative behavior) (Grillner, 2003;
Jahn et al., 2004; Grillner and Jessell, 2009; Maetzler et al., 2013).
The occurrence and frequency of falls, lowered gait velocity
as well as gait and balance disorders are significantly correlated
with WMC in higher age (Baezner et al., 2008; Blahak et al.,
2009; de Laat et al., 2010). For example, a previous study
with 639 adults with a mean age of 74 years showed that
gait velocity was negatively associated with the Fazekas score,
an established measure of presence and severity of WMC
(Baezner et al., 2008). These results were confirmed in another
study (de Laat et al., 2010). A further study in more than
250 older adults with a mean age of 78 years provided
evidence that executive functioning, as measured with the
Trail Making Test (TMT), is negatively associated with the
severity of WMC (Zheng et al., 2012). Another study confirmed
these results (Marshall et al., 2006). Also older adults with
cognitive impairment showed a negative association of executive
functioning with severity and total volume ofWMC (Smith et al.,
2011).
PD patients show similar associations as older adults without
PD. A recent study with 103 early-stage PD patients with
a mean age of 65 years showed that executive functioning
is negatively associated with total WMC volume (Kandiah
et al., 2013). Another study showed that the gait item of the
Unified Parkinson’s Disease Rating Scale (UPDRS) was positively
correlated with the Fazekas score (Sohn and Kim, 1998). Other
studies using comparable paradigms and methods confirmed
basically these results (Theilmann et al., 2013; Veselý et al., 2015;
Veselý and Rektor, 2016).
Overall, there is evidence that presence and severity of
WMC influence gait and executive functioning of older adults
and PD patients. However, it is, to our best knowledge,
not yet investigated whether the factors “age” [used in
this study as a surrogate marker for unspecific progressive
brain degeneration (Fearnley and Leesa, 1991; Moeller
et al., 1996; Volkow et al., 1998; Raz, 2000; Smith et al.,
2007; Raji et al., 2009)] and “PD” (defined here as a type
of specific progressive brain degeneration) are associated
with distinct WMC-related deficits in gait and executive
functioning. Such associations could relevantly affect the
design of prospective studies in this field. To test this
hypothesis, we investigated and compared WMC, gait and
executive functioning in young and old persons with and
without PD.
SUBJECTS AND METHODS
Participants
This cross-sectional study was performed at the Neurology
Department of the University Hospital Tuebingen between
09/2014 and 04/2015. Inclusion criteria were age between 50
and 89 years, the ability to walk at least 20m with or without
walking aid, existence of an axial T2- or FLAIR- (fluid-attenuated
inversion recovery) weighted cerebral MRI sequence, and
provision of a written informed consent. Exclusion criteria were
more than 1 fall per week (for safety reasons), <10 points on the
Mini-Mental State Examination (MMSE) (Folstein et al., 1975)
(to keep the probability high that the instructions were correctly
understood), other neurodegenerative diseases than PD, hospital
admission due to acute stroke, WMC obviously due to other
causes than microangiopathy (e.g., post-ischemic parenchymal
defects >5 cm, vasculitis with cerebral manifestation, hereditary
leukoencephalopathy, normal pressure hydrocephalus, multiple
sclerosis, infectious and autoimmune encephalitis, brain tumor
and metastases). A total of 138 patients who met the above-
mentioned criteria were consecutively recruited. Thirty-seven
patients were classified as PD, and 101 as persons without
PD (Pn). The latter were treated at the neurological ward
due to vascular pathologies (transitory ischemic attack, N = 10;
microangiopathy, N = 9), infectious diseases (N = 7), epileptic
seizures (N = 14), pathologies of peripheral nerves (N =
23), non-degenerative movement disorders (including functional
disorders, N = 23), headache/pain (N = 9), amnesia (N =
4) and orthostatic deficits (N = 2). The investigators excluded
by interview and clinical observation acute conditions that
could relevantly influence the examination. Specifically, any
individuals with limiting pain, hemiparesis, disturbed cognition
and consciousness were excluded. PD patients were investigated
during medication ON phase. Pn and PD subjects were divided
in young (yPn, yPD) and old (oPn, oPD) groups using a cut-
off of 70 years (Dong et al., 2015). Table 1 shows demographic
and clinical parameters of the groups. The study was approved
by the ethical committee of the Medical Faculty at the
University of Tuebingen. All participants gave written informed
consent.
Clinical Assessment
All study participants underwent an extensive clinical, gait
and cognitive assessment, including assessment of medication
and medical history taking. Semi-quantitative assessment of
motor deficits was performed with the motor part of the
revised version of the Unified Parkinson’s Disease Rating Scale
(MDS-UPDRS III) (Goetz et al., 2008), cognitive assessment
with the MMSE (Folstein et al., 1975) and mood assessment
with the Beck Depression Inventory II (BDI II) (Beck et al.,
1996).
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TABLE 1 | Demographic and clinical parameters.
yPn (1) M (range) yPD (2) M (range) oPn (3) M (range) oPD (4) M (range)
Number (female)* 65 (49%) 22 (41%) 36 (42%) 15 (27%) 0.4389
Age (years) 57 (50–69) 62 (49–69) 77 (70–89)1,2 75 (70–89)1,2 <0.0001
MMSE [0–30] 29 (15–30) 29 (17–30) 28 (16–30) 28 (17–30) 0.2107
UPDRS III [0–132] 7 (0–38) 41 (16–78)1,3 12 (0–46) 38 (15–74)1,3 <0.0001
BDI II [0–63] 11 (1–51) 9 (5–34) 11 (1–31) 12 (3–20) 0.9894
LED [mg] – 477 (200–1,350) – 698 (0–1,500) 0.2046
Anticholinergics [% of total]* 2 181 02 131,3 0.0037
Cholinergics [% of total]* 0 5 0 7 0.1229
Sedatives [% of total]* 28 591 192 533 0.0042
Fazekas score [0–3] 1 (0–3) 1 (0–2) 1 (0–3) 1 (0–2) 0.0881
TMT-A [s] 36 (20–180) 51 (25–180) 55 (28–180)1 68 (36–180)1 <0.0001
TMT-B [s] 104 (49–300) 254 (53–300)1 202 (64–300)1 300 (73–300)1 <0.0001
ST walking [m/s] 0.95 (0.41–1.21) 0.91 (0.69–1.15) 0.87 (0.57–1.26) 0.83 (0.29–1.02) 0.0837
ST subtracting serial 7s [N/s] 0.30 (0.12–0.66) 0.29 (0.14–0.63) 0.22 (0.06–0.93)1 0.19 (0.06–0.46)1,2 0.0127
DT walking while subtracting serial 7s [m/s] 0.82 (0.38–1.14) 0.74 (0.51–1.05) 0.72 (0.44–1.37) 0.69 (0.38–0.86)1 0.0053
DT subtracting serial 7s while walking [N/s] 0.33 (0.04–0.81) 0.26 (0.10–0.61) 0.31 (0.02–0.59) 0.27 (0.02–0.51) 0.0891
DTC walking while subtracting serial 7s [%] 9.1 (–7.8 to 44.2) 13.1 (–8.5 to 37.1) 13.7 (–19.2 to 37.1) 19.9 (–1.2 to 43.4) 0.0645
DTC subtracting serial 7s while walking [%] −17.5 (–107.8 to 46.2) –2.8 (–61.6 to 48.2) –20.1 (–101.1 to 79.6) –10.2 (–203.8 to 84.6) 0.4347
Descriptive statistics as well as results of Kruskal-Wallis H test / post hoc Wilcoxon signed-rank tests and *Pearson / post hoc Fisher‘s exact test. Significant results (p < 0.05) are in
bold. 1–4Significant difference (p < 0.05) compared to the group with the number indicated in the first line; BDI II, Beck Depression Inventory II; DT, dual task; DTC, dual task costs; LED,
Levodopa equivalent dosage; M, median; MMSE, Mini-Mental State Examination; N, number; oPD, old patients with Parkinson’s disease (PD); oPn, old persons without PD; ST, single
task; TMT-A, Trail Making Test part A; TMT-B, Trail Making Test part B; UPDRS, Unified Parkinson’s Disease Rating Scale; yPD, young patients with PD; yPn, young persons without PD.
We assessed gait velocity and executive functioning with the
following instruments and tasks.
Testing Simple Executive Functioning without
Mobility
The TMT part A (TMT-A) is considered a relatively simple
task. It measures visual, motor and processing speed
(Bowie and Harvey, 2006). TMT part B (TMT-B) measures
cognitive flexibility (Bowie and Harvey, 2006). Both tests
are predictors of mobility impairment (Vazzana et al.,
2010). They involve the dorsolateral prefrontal cortex,
the medial frontal gyrus, the precentral gyrus and the
supplementary motor area (Bowie and Harvey, 2006). The
TMT has been shown to be sensitive to WMC (Marshall et al.,
2006).
Testing (Simple) Mobility
Gait velocity from a 20m walk at self-selected speed was
used as simple mobility task. It reflects physical performance
and processing speed (Rosano et al., 2008). The parameter
was extracted from the RehaGait R© sensor system (Hasomed
GmbH, Magdeburg, Germany), a validated gait analysis system
(Donath et al., 2016a,b). Based on evidence for the relevance
of this parameter (Baezner et al., 2008; de Laat et al., 2010;
Hollman et al., 2011), we decided to use gait velocity as the
parameter that best reflects quality of gait. The precentral and
cerebellar areas, basal ganglia, (Maetzler et al., 2013) fusiform
and parahippocampal gyri, bilateral inferior frontal gyri and right
supplementary motor area (Jahn et al., 2004) are involved in gait
performance.
Testing Complex Executive Functioning without
Mobility
Wedefined subtracting serial 7s (subtracting a series of 10 steps of
7, starting with a randomly chosen three-digit number) (Hobert
et al., 2011) as a complex executive task. Performance of the task
requires mathematical skills and attention (Yogev et al., 2008).
Testing Complex Executive Functioning Combined
with Mobility
Subtracting serial 7s while walking was used as dual task (DT)
paradigm. Participants subtracted serial 7s from a randomly
chosen three-digit number while simultaneously walking 20m
in normal pace (Hobert et al., 2011). No instruction for
prioritization was given (Yogev-Seligmann et al., 2010). The
task requires mathematical skills, working memory and divided
attention, (Yogev et al., 2008; Patel and Bhatt, 2014) as well
as the activation of supraspinal centers responsible for mobility
coordination (Jahn et al., 2004; Maetzler et al., 2013). The
following brain areas have been shown to be involved in DT,
indicating the complexity of the task: superior (Szameitat et al.,
2002; Nebel et al., 2005) and inferior frontal sulcus (Szameitat
et al., 2002; Collette et al., 2005; Nebel et al., 2005; Deprez
et al., 2013), middle frontal gyrus, (Szameitat et al., 2002; Collette
et al., 2005; Nebel et al., 2005; Deprez et al., 2013) superior
parietal lobe, (Nebel et al., 2005; Deprez et al., 2013) inferior
parietal lobe, (Collette et al., 2005; Nebel et al., 2005) intraparietal
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sulcus, (Szameitat et al., 2002; Collette et al., 2005; Deprez
et al., 2013) anterior cingulate gyrus (Nebel et al., 2005) and
cerebellum (Collette et al., 2005; Deprez et al., 2013). Some of
these brain areas show a direct and positive correlation with
the activity level of the task (Szameitat et al., 2002). Dual task
costs (DTC[%]=(ST-DT)/ST∗100) were defined as the relative
change in performance during DT compared with single task
(ST). Positive DTC reflect a decrease in performance of DT
compared with ST.
Testing Coordination and Prioritization Aspects, and
Complex Executive Functioning Combined with
Mobility
“Coordination and prioritization during DT” can be considered
a very complex task with involvement of coordination,
prioritization and mobility (Hobert et al., 2011; Buss et al., 2014).
DTC may best define quality of this performance. Besides the
brain areas already activated for the performance of DT, an
activation of the following brain areas has been associated with
coordination and prioritization: bilateral middle frontal gyri, left
posterior inferior frontal sulcus, right anterior superior frontal
gyrus and prefrontal cortex (Szameitat et al., 2016).
Assessment of White Matter Changes
Severity of WMC was rated on axial T2- or FLAIR-weighted
images from routine clinical MRIs using the Fazekas score
(Fazekas et al., 1987) in a modified version according to Prins and
Scheltens (2015), which is well established for defining different
groups by severity of WMC (Van Straaten et al., 2006; Ropele
et al., 2009). Absence of lesions in subcortical and periventricular
regions was rated with a score of 0. Focal or punctuate lesions
(diameter of single lesions< 10 mm, diameter of grouped lesions
< 20mm) were rated with a 1 (mild); beginning confluent lesions
(diameter of single lesions between 10 and 20mm, diameter
of grouped lesions more than 20mm, with no more than
connecting bridges between individual lesions) were rated with
a 2 (moderate); and confluent lesions (single lesions or confluent
areas of more than 20mm) with a 3 (severe) (Prins and Scheltens,
2015). Rating of lesions was done by a single rater blinded to
group status. Figure 1 shows examples of differentWMC severity
scores.
STATISTICS
Demographic, clinical, WMC and gait and executive function
parameters across the four groups are presented with median
and range, or frequency. Statistical analysis was performed
with Kruskal-Wallis H / post-hoc Wilcoxon signed-rank test,
or Pearson / post-hoc Fisher’s exact test. We calculated
Spearman correlations between WMC and the gait and
executive performances for each group. For comparisons of
these correlations between groups, we performed Fisher’s z-
transformations. This method accounts for the respective
Spearman’s rho and sample size of each of two groups. Data were
analyzed using the statistical software program JMP R© version
11.2.0 (SAS Institute Inc.).
RESULTS
Table 1 provides details about demographic, clinical, medication,
WMC, gait and executive function parameters of the groups.
The yPn and yPD, as well as oPn and oPD were not relevantly
different regarding demographic and clinical scores, respectively.
As expected, both groups without PD performed better in the
UPDRS than the PD groups (p < 0.001). Levodopa equivalent
dose was not significantly different between yPD and oPD,
and the proportion of participants using cholinergic medication
was comparable across groups (p = 0.12). The proportion of
participants using sedatives (p= 0.004) and anticholinergics (p=
0.004) was significantly different across groups, with comparably
low proportions of study participants without PD that took these
drugs. Presence and severity of WMC were comparable between
the groups (Supplementary Table). Regarding gait and executive
function parameters, yPn performed better in TMT-A, TMT-B
and ST subtracting serial 7s compared to oPn and oPD, better
in DT walking while subtracting serial 7 compared to oPD, and
better compared to yPD in TMT-B. yPD performed better than
oPD in ST subtracting serial 7s.
Details of the correlation analyses between the Fazekas
score and respective gait and executive function parameters are
presented in Table 2 and Figure 2. The following correlations
were significant:
- In yPn, the Fazekas score correlated with the TMT-B. This
value was not significantly different from the values of the other
groups, respectively.
- In yPD, the Fazekas score correlated with the TMT-A. This
correlation was significantly different from the oPn and the
oPD values. yPD also showed a correlation of the Fazekas score
with ST walking. This value was significantly different from the
result found in yPn.
- In oPn, the Fazekas score correlated with the ST subtracting
serial 7s value. This result differed significantly from the yPn
values.
- In oPD, the Fazekas score correlated with both DTC
parameters, i.e., walking while subtracting serial 7s
(significantly different compared to yPn and oPn values)
and subtracting serial 7s while walking (significantly different
compared to the yPn value).
DISCUSSION
This study confirms the already known influence ofWMCon gait
and executive functioning (Schmidt et al., 1993; Baezner et al.,
2008; Blahak et al., 2009; de Laat et al., 2010; De Laat et al., 2011;
Zheng et al., 2012; Theilmann et al., 2013; Prins and Scheltens,
2015). This effect has been shown to be, at least partly, driven
by cognitive reserve (Scarmeas et al., 2003; Steffener et al., 2009;
Brickman et al., 2011; Tucker and Stern, 2011; Stern, 2012; Stern
et al., 2012; Fernandez-Cabello et al., 2016). Moreover, our results
argue for a distinct and selective association between “specific”
(here defined by PD pathology) and “unspecific” (age-related)
brain pathologies and WMC-related gait and executive function
deficits. This latter aspect cannot be explained by cognitive
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FIGURE 1 | Presence and severity of white matter changes in MRI according to the Fazekas score, examples from the actual evaluation. Score 1 (mild) with focal or
punctuate lesions (A); score 2 (moderate) with beginning confluent lesions (B); score 3 (severe) with confluent lesions (C) (Prins and Scheltens, 2015).
reserve models and requires further investigation. Surprisingly,
groups with no or only mild (age or PD-related) signs for
brain pathology (additional toWMC) reflected these associations
only in relatively simple tests, and the groups with signs for
relevant (age and PD-related) brain pathology only in relatively
complex tests. This effect is in our view not explained by potential
confounders, such as medication, as groups with relatively
high proportions of participants taking, e.g., anticholinergics
and sedatives, did not show comparable results regarding the
association betweenWMC-related executive dysfunction and age
and PD.
The group suggested having no or minimal unspecific and
specific brain pathology (yPn) was the only one that showed a
significant association of WMC with TMT-B performance. The
TMT-B is a relatively simple test of cognitive flexibility (Bowie
andHarvey, 2006) and involves circumscribed brain areas (Bowie
and Harvey, 2006). The group suggested having no or minimal
unspecific and some specific brain pathology (yPD) showed
significant associations of WMC with TMT-A performance and
with ST walking. All three above-mentioned parameters (TMT-
A, TMT-B, walking) can be considered as highly processing
speed-dependent (Bowie and Harvey, 2006; Rosano et al., 2008),
again with limited and circumscribed involvement of brain areas
(Jahn et al., 2004; Bowie and Harvey, 2006; Maetzler et al.,
2013). In fact, deficits in processing speed-dependent tasks have
already been shown in young PD patients (Lee et al., 2003).
Based on our results it is tempting to hypothesize that WMC in
middle-aged brains that have no or only mild or specific (here:
dopaminergic) pathology affect mainly and relatively selectively
processing-speed dependent tasks. In other words, processing
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TABLE 2 | Correlation coefficients between white matter changes, and gait and
executive function parameters, sorted by groups.
Spearman’s ρ Spearman’s ρ Spearman’s ρ Spearman’s ρ
yPn (1) yPD (2) oPn (3) oPD (4)
N 65 22 36 15
TMT-A [s] 0.19 0.58**,3,4 0.07 −0.48
TMT-B [s] 0.33* 0.37 0.29 −0.11
ST walking [m/s] 0.05 −0.61**,1 −0.31 −0.11
ST subtracting
serial 7s [N/s]
0.03 −0.19 −0.40*,1 0.19
DT walking while
subtracting serial
7s [m/s]
−0.05 −0.02 −0.20 0.27
DT subtracting
serial 7s while
walking [N/s]
0.08 −0.37 −0.22 0.39
DTC walking
while subtracting
serial 7s [%]
0.14 −0.32 0.02 −0.63*,1,3
DTC subtracting
serial 7s while
walking [%]
0.01 0.05 −0.33 −0.56*,1
White matter changes were rated with Fazekas score. Correlation coefficients were
calculated with Spearman’s rank correlation. *p < 0.05; **p < 0.01. Significant (p <
0.05) group differences in correlations between groups are indicated in bold and by the
group number (1–4). DT, dual task; DTC, dual task costs; N, number; oPD, old patients
with Parkinson’s disease (PD); oPn, old persons without PD; ST, single task; TMT-A, Trail
Making Test part A; TMT-B, Trail Making Test part B; yPD, young patients with PD; yPn,
young persons without PD.
speed dependent tasks are obviously tasks that are receptive to
age-related brain changes at this stage of life (50–70 years of
age). This stage may provide the best target and target range for
WMC that affect areas such as the dorsolateral prefrontal cortex,
the medial frontal gyrus, and the precentral gyrus (Bowie and
Harvey, 2006; Smith et al., 2011).
The significant association of WMC with ST walking
performance in PD patients may further support this hypothesis:
We included patients with Hoehn and Yahr stage 1–3, i.e.,
with relatively preserved gait but already existing walking
deficits (Mancini et al., 2009; King et al., 2012). An additional
pathology, such as WMC, may target here a function that is
in a vulnerable stage without relevant compensation capacity
[omitting a ceiling effect (Maetzler and Hausdorff, 2012)] and
not as advanced to provoke floor effects. In fact, we could not
find a significant association between WMC and ST walking
performance in oPn and oPD, and floor effects may at least
partly explain the lack of significant association of WMC
with some other test parameters (e.g., TMT-B values in oPD,
Table 2).
Attention-related tasks might best reflect the association
between age and WMC. The oPn group showed a significant
association of WMC with ST subtracting serial 7s, a task
relevantly influenced by attention (Yogev et al., 2008).
Comparable to the constellation described in the above
paragraph for less affected groups and other parameters, the
largest range of values of ST subtracting 7s (0.06–0.93, Table 1)
in this cohort suggests that this task provides a good target and
target range for adults with advanced age.
The group defined as having age- and PD-related brain
pathology (oPD) showed significant correlations of WMC with
DTC, which we consider a surrogate for a very complex task
involving many brain areas (Szameitat et al., 2016), i.e., the
simultaneous performance of coordination and prioritization,
and complex executive functioning combined with mobility.
Interestingly, these correlations were negative, indicating that
more WMC lead to lower DTC. The only reasonable explanation
for this phenomenon is, in our view, an unexpectedly poor
ST performance. Patients with multiple brain pathologies may
regularly suffer from apathy, depressive symptoms and loss
of motivation, which may be less prevalent under challenging
conditions (Metzger et al., 2016). Another reason may be
that these simultaneously performed actions trigger each other
reciprocally by serving as internal pulse generators for the
respective other task. This phenomenon has been demonstrated
in 10 healthy subjects with a mean age of 32 years, who showed
an interference of gait rhythmwith fast finger-tapping under dual
tasking conditions (Ebersbach et al., 1995). The posture second
theory as proposed by Bloem et al. (2006) can explain only parts
of the observed effect and may not relevantly contribute to the
explanation of the specific issue described here.
A limitation of the study is that we recruited the cohort
from the ward of a neurological department. We thus cannot
exclude that in particular the yPn and oPn groups do not
exactly reflect the general population. Moreover, group sizes were
relatively unbalanced. This aspect may also explain why many
but not all significant correlation values within groups were also
significantly different to all other groups, respectively. We still
feel that our results are valid and relevant, as the stable pattern of
investigated significant associations betweenWMCand executive
function deficits across the four groups is suggestive of a certain
principle driving these results. We were also able to extensively
evaluate the general and neurological performances and to
use additional assessment information (such as brain imaging)
to ensure that no obvious additional pathology was present.
Still, a re-evaluation of the findings presented here with larger
group sizes, a population-based control group and potentially
longitudinal design would certainly strengthen our results. Such
a study could also test association aspects between age and PD
as well as medication interactions, which were not specifically
addressed here. Furthermore, consideration of cortical atrophy
could also be an interesting addition to such analyses. As a general
comment, the observed effects should be interpreted in the
context of the expected median differences in test performances
across the groups (see also Table 1). Groups suggested having
no or mild brain pathology showed overall better executive
functioning and gait levels than those suggested having specific
and unspecific brain pathology. It is also noteworthy that general
cognition andmood do obviously not relevantly drive our results:
The MMSE and BDI II values were similar across groups.
In conclusion, age and PD-related brain pathology seem to
interact with WMC-related gait and executive function deficits.
Our results should be taken into account when assessment
batteries for studies investigating the influence of WMC on
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FIGURE 2 | Pattern of significant correlations of severity of white matter changes (WMC) with gait and executive function parameters across four groups with and
without advanced age and Parkinson’s disease (PD). DT, dual task; DTC, dual task costs; oPD, old patients with Parkinson’s disease (PD); oPn, old persons without
PD; ST, single task; TMT-A, Trail Making Test part A; TMT-B, Trail Making Test part B; yPD, young patients with PD; yPn, young persons without PD.
gait and executive functioning in older adults and patients
with neurodegenerative diseases are designed. When confirmed
in future studies, these results may also have an influence
on pragmatic management of older adults with WMC and
neurodegenerative diseases in combination with executive and
gait deficits.
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